Elevated serum YKL-40 levels in patients with Kawasaki disease

被引:4
作者
Kim, K. Y. [1 ]
Ahn, Y. [2 ,3 ]
Kim, D. Y. [2 ,3 ]
Kim, Ho-Seong [1 ]
Kim, D. S. [1 ]
机构
[1] Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Pediat, 50 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea
关键词
Kawasaki disease; acute phase reactant; YKL-40; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; HEPATIC-FIBROSIS; PLASMA YKL-40; BIOMARKER; CANCER; INFLAMMATION; PSORIASIS; SURVIVAL; INJURY;
D O I
10.1080/1354750X.2016.1265000
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Context: YKL-40 is an inflammatory biomarker for endothelial dysfunction that may have a role in Kawasaki disease (KD).Objectives: We investigated the association of serum YKL-40 levels with KD and established laboratory parameters for YKL-40 levels and other inflammatory markers.Methods: YKL-40 levels and other inflammatory markers of 23 KD patients, 9 disease control patients and 11 age-matched healthy controls.Results: YKL-40 concentration in the serum of KD patients significantly increased during the acute disease phase compared with those of disease controls and healthy controls.Conclusions: Increased YKL-40 levels may provide a useful inflammatory marker for patients with KD.
引用
收藏
页码:326 / 330
页数:5
相关论文
共 18 条
[1]   Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings [J].
Ahmed, S. F. ;
Attia, E. A. S. ;
Saad, A. A. ;
Sharara, M. ;
Fawzy, H. ;
El Nahrery, E. M. A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (04) :682-688
[2]   Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis? [J].
Erfan, Gamze ;
Guzel, Savas ;
Alpsoy, Seref ;
Rifaioglu, Emine N. ;
Kaya, Sule ;
Kucukyalcin, Volkan ;
Topcu, Birol ;
Kulac, Mustafa .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 400 (1-2) :207-212
[3]   YKL-40 IDENTIFIED BY PROTEOMIC ANALYSIS AS A BIOMARKER OF SEPSIS [J].
Hattori, Noriyuki ;
Oda, Shigeto ;
Sadahiro, Tomohito ;
Nakamura, Masataka ;
Abe, Ryuzo ;
Shinozaki, Koichiro ;
Nomura, Fumio ;
Tomonaga, Takeshi ;
Matsushita, Kazuyuki ;
Kodera, Yoshio ;
Sogawa, Kazuyuki ;
Satoh, Mamoru ;
Hirasawa, Hiroyuki .
SHOCK, 2009, 32 (04) :393-400
[4]   Serum YKL-40 is increased in patients with hepatic fibrosis [J].
Johansen, JS ;
Christoffersen, P ;
Moller, S ;
Price, PA ;
Henriksen, JH ;
Garbarsch, C ;
Bendtsen, F .
JOURNAL OF HEPATOLOGY, 2000, 32 (06) :911-920
[5]   High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival [J].
Johansen, JS ;
Christensen, IJ ;
Riisbro, R ;
Greenall, M ;
Han, C ;
Price, PA ;
Smith, K ;
Brünner, N ;
Harris, AL .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (01) :15-21
[6]   Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity [J].
Johansen, JS ;
Stoltenberg, M ;
Hansen, M ;
Florescu, A ;
Horslev-Petersen, K ;
Lorenzen, I ;
Price, PA .
RHEUMATOLOGY, 1999, 38 (07) :618-626
[7]  
Johansen JS, 2006, DAN MED BULL, V53, P172
[8]   Can YKL-40 be a new inflammatory biomarker in cardiovascular disease? [J].
Kastrup, Jens .
IMMUNOBIOLOGY, 2012, 217 (05) :483-491
[9]   Kawasaki disease [J].
Kim, Dong Soo .
YONSEI MEDICAL JOURNAL, 2006, 47 (06) :759-772
[10]  
Kim KY, 2016, YONSEI MED J, V57, P15